Search Medical Condition
Please enter condition
Please choose location
 

Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric) Clinical Trials

A listing of Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (36) clinical trials

The purpose of this study is to demonstrate the efficacy, safety and tolerability of SPN-810 in the treatment of impulsive aggression in subjects with Attention Deficit/Hyperactivity Disorder (ADHD) in conjunction with standard ADHD treatment. Approximately 291 subjects aged 6 to 12 years with ADHD and comorbid impulsive aggression will be ...

Phase N/A

To evaluate the long-term safety and tolerability of SHP465 at 6.25 mg administered as a daily morning dose in children aged 4-12 years, inclusive, diagnosed with Attention-deficit/Hyperactivity Disorder (ADHD)

Phase

To evaluate the efficacy of SHP465 at 6.25 mg compared to placebo as a daily morning dose in children 6-12 years of age (inclusive at the time of consent) diagnosed with ADHD.

Phase

This is a non-interventional study in children and adolescents (ages 6-17 years) with attention deficit hyperactivity disorder (ADHD) to assess CNVs in specific genes involved in glutamatergic signaling and neuronal connectivity. The screening in this study will be conducted through a combination of online and site performed activities.

Phase N/A

The study is a multicenter, dose-optimized, double-blind, randomized, placebo-controlled, parallel efficacy laboratory classroom study with KP415 in children with Attention-Deficit/Hyperactivity Disorder (ADHD).

Phase N/A

Do you have a child with ADHD who is unable to control his or her anger? Being a parent of a child with ADHD can be challenging. And it can be even harder when the child has sudden outbursts of angry, aggressive behavior. If you or someone you know has ...

Phase

This is a randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety study in children with ADHD in a laboratory classroom setting. The study will be comprised of 3 periods: Screening (up to 35 days) including a 3 - 5 day ADHD medication washout prior to Day -1; Double-blind randomized treatment with either ...

Phase N/A

This study will evaluate the efficacy and safety of high doses of SPN 812 ER in children with ADHD

Phase N/A

This study will evaluate the efficacy and safety of high doses of SPN-812 ER in adolescents (12-17 years old)

Phase N/A

This study is a multicenter, dose-optimized, open-label safety study with KP415 in children with Attention-Deficit/Hyperactivity Disorder (ADHD).

Phase N/A